|1.||Fang, Jun: 3 articles (11/2015 - 02/2013)|
|2.||Maeda, Hiroshi: 3 articles (11/2015 - 02/2013)|
|3.||Nakamura, Hideaki: 3 articles (11/2015 - 02/2013)|
|4.||Ulbrich, Karel: 3 articles (02/2015 - 02/2013)|
|5.||Subr, Vladimir: 2 articles (11/2013 - 02/2013)|
|6.||Ishima, Yu: 1 article (11/2015)|
|7.||Maeda, Hitoshi: 1 article (11/2015)|
|8.||Watanabe, Hiroshi: 1 article (11/2015)|
|9.||Kodama, Azusa: 1 article (11/2015)|
|10.||Tanaka, Ryota: 1 article (11/2015)|
11/20/2013 - "Adenovirus (Ad) was "stealthed" with a new N-(2-hydroxypropyl)methacrylamide polymer, and circulation kinetics were characterized in Balb/C SCID mice (n = 8 per group) bearing human ZR-75-1 xenograft tumors. "
02/01/2015 - "Previously we showed that linear poly(N-(2-hydroxypropyl)methacrylamide) conjugates of pirarubicin (THP), LP-THP, with MW about 39 kDa, exhibited far better tumor accumulation and therapeutic effect than that of parental free THP. "
11/10/2015 - "In this study, we investigated the influence of SNO-HSA-Dimer on the anti-tumor effect of two types of macromolecular anti-tumor drugs, namely N-(2-hydroxypropyl)methacrylamide polymer conjugated with zinc protoporphyrin, which forms micelles and can be used for fluorescence studies. "
09/27/2013 - "Highly decorated: Tumor-associated MUC1 glycopeptide and tetanus toxoid T-cell epitope P2 can be attached to water-soluble poly(N-(2-hydroxypropyl)methacrylamide) carriers by orthogonal ligation techniques. "
02/10/2013 - "We synthesized N-(2-hydroxypropyl)methacrylamide polymer conjugated with zinc protoporphyrin (HPMA-ZnPP) and evaluated its application for tumor detection by imaging and treatment by light exposure using in mouse sarcoma model. "
|2.||Sarcoma (Soft Tissue Sarcoma)
08/01/2004 - "Systemic delivery of adenoviral vectors is a major goal in cancer gene therapy, but is currently prohibited by rapid hepatic uptake of virus following intravenous injection with levels of viable virus in the murine plasma typically falling to less than 0.1% after 30 min. We have used a surface-masking technique based on multivalent copolymers of poly(N-(2-hydroxypropyl)methacrylamide) to ablate all pathways of receptor-mediated infection, combined with dose modulation to achieve partial saturation of nonspecific uptake pathways. "
|3.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|4.||Tetanus Toxoid (Vaccine, Tetanus)
|1.||Heterologous Transplantation (Xenotransplantation)